Skip Navigation LinksHome > Published Ahead-of-Print > Feasibility of At-Home Self-Sampling for HPV Testing as an A...
Journal of Lower Genital Tract Disease:
doi: 10.1097/LGT.0000000000000051
Original Article: PDF Only

Feasibility of At-Home Self-Sampling for HPV Testing as an Appropriate Screening Strategy for Nonparticipants in Switzerland: Preliminary Results of the DEPIST Study.

Catarino, Rosa Jr MD; Vassilakos, Pierre MD; Stadali-Ullrich, Heidrun MD; Royannez-Drevard, Isabelle; Guillot, Cécile; Petignat, Patrick PD, MD

Published Ahead-of-Print
Collapse Box

Abstract

Objective: Nonattendees to cervical cancer screening are at a higher risk of developing cervical cancer. This study assessed women's willingness to perform a home-based self-sampling for human papillomavirus testing (Self-HPV) and explored the feasibility of establishing a home-based Self-HPV screening strategy in Switzerland.

Materials and Methods: Underscreened women (n = 158) who had not underwent a Pap test in the preceding 3 years were recruited between September 2011 and September 2013. Participants completed 2 questionnaires evaluating reasons for non-attendance at a screening program, sociodemographic issues, and satisfaction with and acceptability of the Self-HPV. Descriptive data and multivariate logistic regression were used to identify variables associated with women's willingness to perform at-home self-sampling for HPV testing.

Results: Lack of time because of work or childcare was the most common reason for nonattendance at a screening program. One hundred six women (82%) preferred the Self-HPV because it is easy to perform, convenient, comfortable, and private. Women were more likely to accept the Self-HPV as a future screening strategy if they had missed cervical cancer screening in the past because of lack of time (odds ratio [OR] = 6.2, 95% confidence interval [CI] = 1.6-23.6; p < .01). Twenty-six women felt pain during self-sampling. Previous negative experiences with screening and stress during sampling were associated with higher risk for pain (OR = 7.14, 95% CI = 2.0-25.3, p < .01 and OR = 4.73, 95% CI = 1.5-14.5, p < .01, respectively).

Conclusions: The Self-HPV was accepted by nonattendees of cervical cancer screening programs. Self-sampling may promote screening among the unscreened and underscreened population of women in Switzerland while overcoming some practical barriers.

Copyright (C) 2014 by the American Society for Colposcopy and Cervical Pathology

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.